Jianmin Pharmaceutical Group Co Ltd Financial Flexibility Index
Jianmin Pharmaceutical Group Co Ltd financial flexibility index. Jianmin Pharmaceutical Group Co Ltd (600976) has a Financial Flexibility Index of 0.07x as of December 2025. Free cash flow of CN¥130.05 Million (operating CF CN¥106.82 Million minus capex CN¥23.23 Million) represents 0% of total liabilities (CN¥1.81 Billion). See 600976 free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Jianmin Pharmaceutical Group Co Ltd (2003–2025)
Financial flexibility index of Jianmin Pharmaceutical Group Co Ltd from 2003 to 2025. Historical Financial Flexibility Index trend for Jianmin Pharmaceutical Group Co Ltd across 23 annual periods. Check 600976 operating cash flow to net income to evaluate the quality of earnings relative to operating cash generation.
Jianmin Pharmaceutical Group Co Ltd Financial Flexibility Index by Year (2003–2025)
Jianmin Pharmaceutical Group Co Ltd financial flexibility index by year from 2003 to 2025. Year-by-year free cash flow to debt coverage for Jianmin Pharmaceutical Group Co Ltd. For the full cash flow conversion analysis, see 600976 operating cash flow.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.21x | CN¥375.20 Million | CN¥274.53 Million | CN¥1.81 Billion | ▲ +7.1% |
| 2024 | 0.19x | CN¥354.55 Million | CN¥234.27 Million | CN¥1.83 Billion | ▲ +11.4% |
| 2023 | 0.17x | CN¥332.89 Million | CN¥268.39 Million | CN¥1.91 Billion | ▼ -3.7% |
| 2022 | 0.18x | CN¥283.83 Million | CN¥215.87 Million | CN¥1.57 Billion | ▼ -27.9% |
| 2021 | 0.25x | CN¥315.17 Million | CN¥259.18 Million | CN¥1.26 Billion | ▲ +60.2% |
| 2020 | 0.16x | CN¥171.12 Million | CN¥125.54 Million | CN¥1.09 Billion | ▼ -21.6% |
| 2019 | 0.20x | CN¥143.76 Million | CN¥74.45 Million | CN¥720.63 Million | ▲ +8.7% |
| 2018 | 0.18x | CN¥105.97 Million | CN¥63.60 Million | CN¥577.11 Million | ▲ +94.4% |
| 2017 | 0.09x | CN¥77.13 Million | CN¥35.20 Million | CN¥816.71 Million | ▼ -48.8% |
| 2016 | 0.18x | CN¥143.26 Million | CN¥113.84 Million | CN¥776.45 Million | ▲ +42.7% |
| 2015 | 0.13x | CN¥78.20 Million | CN¥48.45 Million | CN¥604.72 Million | ▼ -45.8% |
| 2014 | 0.24x | CN¥130.00 Million | CN¥103.23 Million | CN¥544.79 Million | ▲ +74.0% |
| 2013 | 0.14x | CN¥69.26 Million | CN¥45.36 Million | CN¥504.92 Million | ▼ -54.2% |
| 2012 | 0.30x | CN¥107.14 Million | CN¥98.17 Million | CN¥357.90 Million | ▲ +230.0% |
| 2011 | -0.23x | CN¥-67.09 Million | CN¥-75.54 Million | CN¥291.28 Million | ▼ -133.9% |
| 2010 | 0.68x | CN¥155.49 Million | CN¥150.08 Million | CN¥228.78 Million | ▲ +298.3% |
| 2009 | 0.17x | CN¥81.19 Million | CN¥66.69 Million | CN¥475.79 Million | ▼ -42.9% |
| 2008 | 0.30x | CN¥118.79 Million | CN¥110.11 Million | CN¥397.80 Million | ▲ +1313.5% |
| 2007 | 0.02x | CN¥3.02 Million | CN¥-6.88 Million | CN¥143.07 Million | ▼ -91.7% |
| 2006 | 0.26x | CN¥72.79 Million | CN¥56.18 Million | CN¥285.18 Million | ▲ +577.2% |
| 2005 | -0.05x | CN¥-16.12 Million | CN¥-34.63 Million | CN¥301.33 Million | ▼ -119.0% |
| 2004 | 0.28x | CN¥61.78 Million | CN¥4.13 Million | CN¥219.38 Million | ▼ -33.2% |
| 2003 | 0.42x | CN¥102.07 Million | CN¥4.19 Million | CN¥242.31 Million | — |